MAKE SALARY CHILLAR AGAIN

Stocks | Wealth | Freedom

BHARTIY NIVESHAK

|| Upgrade Your Life ||

Fee: ₹35,999 ⌛ 2026 Batch started on March 28 JOIN DNA 2026 NOW
Fee: ₹35,999 ⌛ started on March 28 JOIN DNA 2026

Platform Business Squeezing Volatility To Melt Up? 0 (0)

Platform businesses are not stranger to us by now. Most of the platform businesses get help from being no to marginal cost with each new consumer/user on the platform. That means bulk of the topline(sales) starts going to bottomline(profits). Why these two items are called topline and bottomline? Because they appear at the top and …

This content is for PRO members only.
Join Now
Already a member? Log in here

Value Investor vs Price Action Follower 5 (1)

We often say that it is a structural story to many stock. What do we mean by that? Structural story in terms of the future trend, industry direction and particular business direction. But does that mean as a shareholder you will make money in all such structural stories? Not necessarily. You see that is why …

This content is for PRO members only.
Join Now
Already a member? Log in here

Intrinsic Value? Fair Value? Is there Any Value in Calculating Them? 5 (4)

You will often see people calculating the value which they think business should trade at. Often it is known as fair value or intrinsic value of a company. It involves a lot of elaborate models with many variables. Usually the more complex it is better people consider it. Because more complexity is taken as a …

This content is for PRO members only.
Join Now
Already a member? Log in here

Was Price Action Telling Something That We Ignored? 5 (1)

Pharma has been the flavour of the market moves right after the last week of March 2020. There were talks of global supply chain derisking itself from enormous risk due to unsustainable dependence on China. Indian Pharma listed space started buzzing after 5 years of clear downtrend. There were businesses which doubled the topline and …

error: Content is protected !!